Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine

This single-center study included 68 multiple sclerosis (MS) patients who received the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination from one of several approved vaccine preparations in Spain. Blood samples were collected one to three months after the second dose of the va...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodero-Romero, Alexander, Sainz de la Maza, Susana, Fernández-Velasco, José Ignacio, Monreal, Enric, Walo-Delgado, Paulette Esperanza, Chico-García, Juan Luis, Villarrubia, Noelia, Rodríguez-Jorge, Fernando, Rodríguez-Ramos, Rafael, Masjuan, Jaime, Costa-Frossard, Lucienne, Villar, Luisa María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535818/
https://www.ncbi.nlm.nih.gov/pubmed/37766078
http://dx.doi.org/10.3390/vaccines11091399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535818/
https://www.ncbi.nlm.nih.gov/pubmed/37766078
http://dx.doi.org/10.3390/vaccines11091399

Ejemplares similares